RemeGen Co: Clinical Trials & Research Profile

Biopharma Industry (Global / Institutional) · Primary Focus: Oncology and Hematology

Clinical Trial MetricVerified Public Record
Organization TypeConsolidated Trial Sponsor
Institutional Sector & LocationBiopharma Industry (Global / Institutional)
Primary Therapeutic AreaOncology and Hematology
Active Phase II & III Studies27 active (20 recruiting now)
Total Tracked Studies (2018 to 2026)61 (1 with California sites)
Completed vs Early-Stopped Studies16 completed / 4 stopped (6.6% stop rate)
Median Closed Enrollment44 participants
FDA Drugs@FDA Original Approvals0 all-time (0 from 2018 to 2026)
Physical Hospital Site Disclosure99.1% named hospital slots

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI -> · AI for Healthcare · Healthcare Price & Patent Cliff Crosswalk